The 20 Best Prostatectomy Doctors near Falls Church, VA

Peter Choyke is a Radiologist practicing medicine in Bethesda, Maryland. Dr. Choyke is rated as an Elite provider by MediFind in Prostatectomy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Congenital Hepatic Fibrosis, Desmoid Tumor, Prostatectomy, and Endoscopy.

Peter Pinto is a Urologist practicing medicine in Bethesda, Maryland. Dr. Pinto is rated as an Elite provider by MediFind in Prostatectomy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Dr. Inger Rosner is a board-certified urologic oncologist. She joined Inova Health System in 2020 and has been practicing urologic oncology since 2007. Prior to joining Inova, Dr. Rosner was the Director of the Urologic Oncology Service at Walter Reed National Military Medical Center. Additionally, she was the Director of the Center for Prostate Disease Research at Uniformed Services University of the Health Sciences. Dr. Rosner was the Principal Investigator for several research protocols and clinical trials and has published dozens of papers based on her research in the field of urology oncology. She is interested in patient health care disparities and quality of life outcomes in patients diagnosed with and treated for prostate cancer along their continuum of cancer care. Additionally, her clinical interests include multi-disciplinary care of urologic cancer patients from the newly diagnosed to the advanced stages of disease. She specializes in minimally-invasive and robotic-assisted surgery. Dr. Rosner received her Doctor of Medicine from Uniformed Services University and completed her surgical residency in urology at Walter Reed Army Medical Center. She did her fellowship training in urologic oncology at the National Cancer Institute. Dr. Rosner served 23 years on active duty service in the United States Army and retired as Colonel. Dr. Rosner is married to Dr. Michael Rosner, a neurosurgeon at George Washington University Hospital in Washington, DC. They have three sons and live in Bethesda, MD. Dr. Rosner is rated as a Distinguished provider by MediFind in Prostatectomy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Nephrectomy.

Sandeep Bagla is an Interventional Radiologist practicing medicine in Falls Church, Virginia. Dr. Bagla is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Osteoarthritis, Arthritis, Prostatic Artery Embolization, and Aquablation.

Manie Juneja is an Internal Medicine specialist and a Geriatrics provider practicing medicine in Falls Church, Virginia. Dr. Juneja is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Vitamin D Deficiency, Sepsis, Necrosis, Hip Replacement, and Pacemaker Implantation.

Kevin Mccammack is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Mccammack is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ascites, Visceromegaly, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Bone Marrow Aspiration.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Advanced provider by MediFind in Prostatectomy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Advanced provider by MediFind in Prostatectomy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Dr. Zain Abedali is a specialty care physician board certified in urology. He joined Inova in 2025 and has been practicing since 2020. Prior to joining Inova, Dr. Abedali completed his urology residency at the Indiana University School of Medicine, Department of Urology—one of the nation’s leading programs for urologic surgical training. Dr. Abedali provides comprehensive care for conditions affecting both the male and female urinary tracts. His clinical expertise includes the medical and surgical management of kidney stones, benign prostatic hyperplasia (BPH), and erectile dysfunction (ED). He also has extensive experience treating the full spectrum of genitourinary cancers, including prostate, kidney, bladder, and testicular cancer. He is trained in advanced surgical techniques, including both open and minimally invasive/robotic approaches. Known for being a thoughtful and attentive listener, Dr. Abedali strives to build strong partnerships with his patients. He emphasizes shared decision-making, patient autonomy, and quality of life, tailoring care to meet the diverse needs of the Northern Virginia community. Outside of medicine, Dr. Abedali is an avid runner who enjoys hiking and spending time with his family while exploring the Northern Virginia region. Dr. Abedali is rated as an Experienced provider by MediFind in Prostatectomy. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Cystectomy.

Dr. Edmond Paquette is a specialty care physician board certified in urology at Inova. He joined Inova in 2017. Before joining Inova, Dr. Paquette practiced at Dominion Urology in Fairfax, VA. Dr. Paquette graduated from the University of Rhode Island in South Kingstown, majoring in zoology and graduating with honors, then obtained his medical degree from Brown University School of Medicine in Providence, RI. He completed a surgical internship at Madigan Army Medical Center in Fort Lewis, WA, followed by two years of service as a general medical officer with the United States Army in Germany and Bosnia. Upon his return, Dr. Paquette completed his residency in urology at Walter Reed Army Medical Center, where he also spent one year as a research fellow studying the epidemiology and treatment of prostate cancer. Following residency, Dr. Paquette became Chief of Urology and Interim Chief of Surgery at Womack Army Medical Center in Fort Bragg, NC. While in the military, Dr. Paquette served with the 10th Combat Support Hospital in Baghdad during Operation Iraqi Freedom. He was honorably discharged after 13 years of service as a lieutenant colonel, having received the Meritorious Service Medal twice, the NATO Medal, the Overseas Ribbon and the War on Terrorism Medal. Dr. Paquette has authored nearly two dozen peer-reviewed scholarly articles. His primary interests include the treatment of benign prostate hyperplasia, kidney stones, reconstructive urology, prosthetics, male incontinence, erectile dysfunction, vasectomy reversal and prostate cancer. He is currently an Associate Professor of Surgery at the University of Virginia School of Medicine and is the Co-Clerkship Director for the University of Virginia School of Medicine’s urology rotation on the Inova campus. Dr. Paquette is certified by the American Board of Urology and is a fellow of the American College of Surgeons. Outside the office, Dr. Paquette enjoys coaching his five children in basketball and soccer. Dr. Paquette is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Paulina Wilson is a specialty care physician board certified in urology at Inova Health System. She joined Inova in 2015 upon completion of her surgical training in the Washington, DC, area. Dr. Wilson’s focus includes general urology; men’s health; the evaluation, surgical management and prevention of kidney and bladder stones; management of voiding issues in men and women including difficulties with urination, frequent or urgent urination, incontinence and other concerns; minimally invasive procedures for urinary incontinence; surgical management of scrotal and testicular conditions; prevention and treatment of urinary infections; and medical and surgical management of erectile dysfunction. Her goal is to give patients high-quality, holistic, innovative and personalized care and to empower those with urologic conditions to make the best decisions for their health. A native of the DC metro area, Dr. Wilson is committed to serving the people in her community. She attended the University of Maryland for her undergraduate education and earned her medical degree from the University of Maryland School of Medicine. Dr. Wilson completed her urologic surgical residency at George Washington University Hospital, where she was also associated with Sibley Memorial Hospital, Children’s National Hospital and the National Institutes of Health’s Urologic Oncology Branch as part of her surgical and clinical education. Outside the office, Dr. Wilson enjoys spending time with her husband and daughters, cooking, enjoying the outdoors, and traveling. Dr. Wilson is rated as an Experienced provider by MediFind in Prostatectomy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses UPJ Obstruction, Bilateral Hydronephrosis, Obstructive Uropathy, Ureteroscopy, and Prostatectomy.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as an Experienced provider by MediFind in Prostatectomy. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Schar Chair, Advanced Lung Disease and Lung Transplant Medical Director, Advanced Lung Disease and Lung Transplant Program, Inova Schar Heart and Vascular Professor of Medical Education, University of Virginia, Inova CampusSteven D. Nathan, MD, FCCP, is the medical director of Inova’s Advanced Lung Disease Program and Lung Transplant Program. He is also a professor of medicine at the University of Virginia.Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences. Dr. Nathan is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy.

Kenneth Tseng is a Pain Medicine specialist and an Anesthesiologist practicing medicine in Falls Church, Virginia. He has been practicing medicine for over 17 years. Dr. Tseng is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Acute Pain, Spinal Stenosis, and Prostatectomy.

Habib Chotani is a primary care provider, practicing in Internal Medicine in Alexandria, Virginia. Dr. Chotani is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Lung Cancer, Type 2 Diabetes (T2D), Vitamin D Deficiency, Prostatectomy, and Hernia Surgery.

Yousef Salem is a Urologist practicing medicine in Alexandria, Virginia. Dr. Salem is rated as an Advanced provider by MediFind in Prostatectomy. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Familial Prostate Cancer, Prostate Cancer, Prostatectomy, and Ureteroscopy.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Advanced provider by MediFind in Prostatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Experienced provider by MediFind in Prostatectomy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Jarrett is board certified in American Board Of Urology.